The KRAS Variant as a Predictive Biomarker of Cetuximab Response in Head and Neck Cancer

Affiliations

• ¹ Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
• ² Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada2Division of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
• ³ Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada4Departments of Radiation Oncology and Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.